乳腺癌前哨淋巴结实时三维超声造影的初步研究
本研究前瞻性纳入2016年6月至2017年12月经病理确诊的T1/2期乳腺癌女性患者,行三维超声造影(3D-CEUS)检查并最终行蓝染法前哨淋巴结活检(SLNB)。3D-CEUS检出淋巴引流途径与术后病理及蓝染结果的符合率为97.4%,诊断转移淋巴结的敏感度75%、特异度93.0%、阳性预测值81.8%、阴性预测值89.9%、淋巴结检出率95.3%、正确诊断率87.7%。结论认为3D-CEUS是检出前哨淋巴结和淋巴管的一种可行且有用的新方法,能准确定位淋巴管和前哨淋巴结并评估转移淋巴结的存在。
要点
- 3D-CEUS可显示前哨淋巴结及淋巴引流途径的立体走向,淋巴引流途径符合率达97.4%。
- 3D-CEUS诊断转移淋巴结敏感度75%、特异度93.0%、正确诊断率87.7%。
- 3D-CEUS淋巴结检出率95.3%,可准确定位淋巴管和前哨淋巴结。
核心结论
- 3D-CEUS是检出前哨淋巴结和淋巴管的一种可行且有用的新方法。
- 3D-CEUS能准确定位淋巴管和前哨淋巴结并评估转移淋巴结的存在。
研究设计与样本
- 前瞻性研究,纳入2016年6月至2017年12月经病理确诊的T1/2期乳腺癌女性患者。
- 患者接受3D-CEUS检查,最终均行蓝染法前哨淋巴结活检(SLNB)。
- 以术后病理及蓝染显示的淋巴引流途径为参考,评估3D-CEUS的检出与诊断效能。
关键影像表现/征象
- 3D-CEUS可显示前哨淋巴结的数目、大小、位置及增强模式,并显示淋巴引流途径的立体走向。
- 根据术后病理及蓝染淋巴引流途径,共分为六种淋巴引流途径模式,3D-CEUS的符合率为97.4%。
诊断标准与关键数值
- 3D-CEUS检出淋巴引流途径与术后病理及蓝染结果的符合率为97.4%。
- 3D-CEUS诊断转移淋巴结的敏感度为75%、特异度为93.0%、阳性预测值为81.8%、阴性预测值为89.9%。
- 3D-CEUS的淋巴结检出率为95.3%,正确诊断率为87.7%。
临床应用与阅片要点
- 3D-CEUS可术前标记淋巴管和前哨淋巴结的体表位置及引流路径,辅助SLNB定位。
- 3D-CEUS可评估前哨淋巴结是否存在转移,敏感度75%、特异度93.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the clinical value of real-time three-dimensional contrast-enhanced ultrasound (3D-CEUS) in the detection of sentinel lymph nodes (SLNs) and drainage lymphatics in breast cancer patients.
METHOD: The prospective study was performed in women with pathology-confirmed T1/2 breast cancer between June 2016 and December 2017 who underwent sentinel lymph node biopsy and 3D-CEUS. The number, size, location, enhancement pattern of SLNs, and the lymphatic drainage patterns were reviewed. The routes, location of SLNs, and lymph channels (LCs) on the surface were marked. All patients underwent blue dye-guided sentinel lymph node biopsy (SLNB) finally.
RESULTS: According to the postoperative pathology findings and the blue dye staining of the lymphatic drainage routes, there are six patterns of lymphatic drainage routes and the coincidence rate of the 3D-CEUS was 97.4%; the sensitivity, specificity, positive predictive value, negative predictive value, the LN detection rate, and the correct diagnosis rate of the 3D-CEUS were 75%, 93.0%, 81.8%, 89.9%, 95.3%, and 87.7%, respectively.
CONCLUSION: 3D-CEUS is a new feasible and useful approach to detect the SLNs and LCs. 3D-CEUS can accurately localize the LCs and SLNs and estimate the presence of metastatic lymph nodes.
KEY POINTS: • The three-dimensional contrast-enhanced ultrasound can detect the sentinel lymph nodes. • The three-dimensional contrast-enhanced ultrasound can show the stereo direction of sentinel lymph nodes and lymph drainage routes. • The three-dimensional contrast-enhanced ultrasound can accurately localize the LCs and SLNs and estimate the presence of metastatic lymph nodes.
引用
- Hu Z, Cheng X, Li J, et al. Preliminary study of real-time three-dimensional contrast-enhanced ultrasound of sentinel lymph nodes in breast cancer. Eur Radiol. 2019. PMID: 31776739. doi:10.1007/s00330-019-06494-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。